Ifosfamide: Clinical Trials

10 trials of Ifosfamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 unknown, 1 recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Unknown 4, Recruiting 1

Follow Ifosfamide: new trials by email Literature Review of Ifosfamide trials Research Report on Ifosfamide

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Vincristine, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin hydrochloride, Etoposide, Ifosfamide, Methotrexate, vincristine - Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma
Phase 4RecruitingFederal Research Institute of Pediatric Hematology, Oncology and Immunology3002022-05-252022-08-26
Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
Patients starting a treatment with Doxorubicin and Ifosfamide - Soft Tissue Sarcoma
Phase 4CompletedInstitut Claudius Regaud592018-05-182026-04-14
Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas
cisplatin, ifosfamide, gemcitabine - Peripheral T Cell Lymphoma
Phase 4UnknownThe University of Hong Kong502017-02-242018-06-11
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma
Cyclophosphamide 750mg/m2, Vincristine 1.4mg/m2, Doxorubicin 50mg/m2 - ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified
Phase 4UnknownRuijin Hospital2002012-09-012017-11-14
Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors
craniospinal irradiation, Carboplatin, Etoposide, Ifosfamide, ventricular irradiation - Intracranial Germ Cell Tumors
Phase 4UnknownUniversity Hospital Muenster4002011-10-012015-06-04
Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults
Rituximab - Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
Phase 4UnknownUniversity of Bologna252006-12-012009-09-15
Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
Adriamycin, Cyclophosphamide, Cytarabine - Burkitt's Lymphoma, Burkitt's Leukemia
Phase 4CompletedNicola Goekbuget6502002-07-012022-08-19
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)
Dexamethasone / Prednisolone, Cyclophosphamide, Methotrexate - Adult Acute Lymphocytic Leukemia
Phase 4CompletedGoethe University2251999-10-012023-03-20
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia
Adriamycin, Cyclophosphamide, Cytarabine - Adult Acute Lymphocytic Leukemia
Phase 4CompletedGoethe University401997-02-012023-03-20
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Asparaginase, Vincristine, Daunorubicin, Adriamycin - Adult Acute Lymphocytic Leukemia
Phase 4CompletedGoethe University7201993-04-012023-03-17

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Burkitt Lymphoma (2)  ·  Enteropathy-Associated T-Cell Lymphoma (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Mediastinal Neoplasms (1)  ·  Sarcoma (1)  ·  Subcutaneous panniculitis-like T-cell lymphoma (1)

Sponsors

Goethe University (3)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Institut Claudius Regaud (1)  ·  Nicola Goekbuget (1)  ·  Ruijin Hospital (1)  ·  The University of Hong Kong (1)  ·  University Hospital Muenster (1)  ·  University of Bologna (1)

Countries

Germany (5)  ·  China (1)  ·  France (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Russia (1)

Top investigators

Dieter Hoelzer, MD (1)  ·  Dieter Hoelzer, MD, PhD (1)  ·  Dieter Hoelzer, MD,PhD (1)  ·  Gabriele Calaminus, MD (1)  ·  Giovanni Martinelli, MD (1)  ·  Nicola Goekbuget, Dr. med. (1)  ·  Yok Lam Kwong, MBBS (1)

Results publications

PMID 19144982, PMID 22442346, PMID 22493293, PMID 25359988, PMID 27561722, PMID 28751559, PMID 33633029, PMID 36882147

NIH funding

2009 (1)